Our Proprietary Deal Flow – Project Code Name: “CARE”

Back

Water Treatment - Investment Opportunities

Prescription & OTC drugs

Mid Cap

Asia

Joint Venture

Minority up to Majority

Integrated Pharmaceuticals company based in ASEAN which manufactures and distributes its own branded products, both generic prescription drugs & OTC products

Key investment considerations:

  • USD 50 M revenue with 15% EBITDA
  • 2 factories (total of 40,000 sqm)
  • 60% of the products are distributed and sold locally, 40% of products exported
  • Family owned and run company